Johnson & Johnson (NYSE:JNJ) has officially named Shawn Millerick as the president of Vision Care, Americas. His appointment commenced on November 11, 2024. Millerick will spearhead the development of strategy and steer the expansion of the company’s Vision Care portfolio in both North America and Latin America, encompassing the highly acclaimed Acuvue contact lenses.
The company emphasized Millerick’s commitment to hastening digital innovation to enhance patient and eye care professional outcomes. “Bringing Shawn into our Vision Care leadership across North America and LATAM is exhilarating. His outstanding leadership and profound knowledge will act as a transformative force for our prospective growth,” remarked Peter Menziuso, Company Group Chairman, Vision, Johnson & Johnson MedTech.
Millerick’s vast experience includes crafting commercial strategies and enterprise solutions, along with an extensive background in consumer healthcare. He possesses expertise in over-the-counter marketing, emphasizing shopper marketing and category insight extraction.
“Rejoining the vision sector and being part of a team focused on making a positive difference in lives is an honor. I am genuinely motivated by the journey ahead and the chance to contribute to a mission that resonates personally with me: Vision Made Possible,” said Millerick.
With Millerick stepping into his new role, Erin Powers now assumes broader duties as she leads North America’s Surgical Vision operations as Vice President.
Collaboration between Millerick and Powers is anticipated to amplify growth for both Vision Care and Surgical Vision. Johnson & Johnson anticipates their alignment on opportunities, synergies, and culture as a cohesive unit within the Vision organization.